mRNA-1018-H5 for influenza in birds

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Mar 2026: Trial started, NCT07496450
  2. 27 Mar 2026: Trial registered, NCT07496450

The trials

NCT07496450: A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

State
Under way
Phase
Phase 3
People
4,050 taking part
Started
23 Mar 2026
Primary completion
28 Jan 2027
Arms
mRNA-1018-H5 Vaccine
Results
None posted
  1. 23 Mar 2026: Trial started
  2. 27 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.